1. Home
  2. NL vs CERS Comparison

NL vs CERS Comparison

Compare NL & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NL Industries Inc.

NL

NL Industries Inc.

HOLD

Current Price

$6.96

Market Cap

288.3M

Sector

Industrials

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.71

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NL
CERS
Founded
1891
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
288.3M
276.0M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
NL
CERS
Price
$6.96
$2.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.4K
2.8M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
10.22%
N/A
EPS Growth
N/A
27.27
EPS
0.09
N/A
Revenue
$158,285,000.00
$51,326,000.00
Revenue This Year
$9.32
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
$80.33
N/A
Revenue Growth
8.46
30.68
52 Week Low
$5.04
$1.15
52 Week High
$8.60
$3.15

Technical Indicators

Market Signals
Indicator
NL
CERS
Relative Strength Index (RSI) 67.07 67.67
Support Level $5.42 $1.89
Resistance Level N/A $3.05
Average True Range (ATR) 0.37 0.23
MACD 0.15 0.01
Stochastic Oscillator 47.54 72.00

Price Performance

Historical Comparison
NL
CERS

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: